Study finds no link between short-term immunosuppressant use and cancer

Relatively short-term use of immunosuppressant medications to control an inflammatory disease was not associated with an increased risk of later developing cancer, according to new research led by scientists at the University of Pittsburgh and Mass Eye and Ear, a member of the Mass General Brigham health care system, and published today in the journal BMJ Oncology.

Related Keywords

John Kempen ,Lily Ramsey ,Jeanine Buchanich ,University Of Pittsburgh ,Pitt Public Health Center ,Harvard Medical School ,Pitt School Of Public Health ,Mass Eye ,Mass General Brigham ,Systemic Immunosuppressive Therapy ,Eye Diseases ,Pitt Public Health ,Occupational Biostatistics ,Cancer ,Blindness ,Ear ,Epidemiology ,Eye ,Health Care ,Hospital ,Immunosuppression ,Inflammatory Disease ,Medical School ,Neck ,Ncology ,Ophthalmology ,Mh ,Public Health ,Research ,Surgery ,Throat ,Transplant ,